Accutar Biotech

Accutar Biotech is a New York City-based artificial intelligence company in the healthcare sector [1]. The company employs artificial intelligence in drug discovery, with capabilities including side chain flexible mode ligand docking, virtual screening, and drug ADME property prediction [2]. Accutar's platform operates through a hybrid approach combining computational drug design with wet lab validation [2]. According to company information, this methodology reduces the time and cost requirements of traditional drug discovery efforts [2]. The company has 37 employees and operates in the biotechnology research industry [3].

Something wrong or missing? Send a correction. Fixed within 24 hours.